semaglutide fda approval date approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA Clears Semaglutide For Cardiac

Additionally, the option of taking Wegovy without injections may align better with busy or travel-heavy schedules

Weight loss accounts for some improvement, but clinical trials show additional cholesterol and triglyceride reductions beyond what weight loss alone would predict

Metoprolol (Oral Route)

Founded in 2021, the platform has rapidly scaled while maintaining the kind of quality markers published clinical research, CoA testing, lab work, and dietitian access that define best-in-class GLP-1 care

Our Medically Supervised Weight Loss Program is designed to help you reach your goals safely and effectively, using two personalized treatment options